PRNewsWire · November 13, 2026
Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: PRNewsWire ↗